Medical education company Simbionix USA Corp. has added two board members who are also investors in the company. Glen Mayfield of Cincinnati-based River Cities Capital Funds, which invested in Simbionix in 2008, brings more than 40 years of private equity and banking experience to the board, according to a statement. The second new board member […]
Total capital raised corrected 8:13 p.m., June 23, 2010. OrthoHelix Surgical Designs Inc. has added a $4.6 million cherry on top of its third fundraising round for a total of $14 million raised since early 2008. The company that recently relocated to Medina from Akron, Ohio, develops and makes implants and instruments that surgeons can […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Eight venture capitalists gathered Thursday evening at TechColumbus to discuss bioscience innovation in the state. The audience included a mix of start ups, portfolio companies and research institutions trying to navigate their way into the panelists' pockets.
The Myriad is a minimally invasive surgical tool to remove all soft tumor tissue in the central nervous system. The company says it cuts procedure times and gives surgeons better control for difficult tissue shaving around critical areas in the body.
The money was added to a $7.3 million round last year. The company will use the money to expand and sell into 40 states. (It's currently in 25.)